RxDoctor Payments Data

Alan Jubane, MD

Family Medicine · Shelby, NCNPI 1710965322

Payments from drug & device makers

$9,915in general payments, 2019–2025

Across 625 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$885
  • Novo Nordisk$788
  • Johnson & Johnson$767
  • Bayer$555
  • Astellas Pharma US Inc$541
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$9,63697%
  • Education$2793%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,915 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,280
Medicare patients
48
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin263$258,811
OzempicSemaglutide176$205,563
TrulicityDulaglutide144$184,751
LinzessLinaclotide134$124,334
EliquisApixaban122$118,232
FarxigaDapagliflozin Propanediol81$74,289
XareltoRivaroxaban51$47,003
Invega SustennaPaliperidone Palmitate13$46,542
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$39,356
Spiriva HandihalerTiotropium Bromide46$34,376
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr66$33,315
MyrbetriqMirabegron26$30,418
SymbicortBudesonide/Formoterol Fumarate99$26,860
VraylarCariprazine Hcl15$23,592
JanuviaSitagliptin Phosphate17$20,900

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$498$289,432295 claims
Novo NordiskOzempic, Rybelsus$788$220,309190 claims
Lilly USA, LLCTrulicity$369$184,751144 claims
AbbVieLinzess, Vraylar$1,914$147,926149 claims
PfizerEliquis, Nurtec Odt$356$138,088138 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$885$116,858201 claims
Johnson & JohnsonXarelto, Invega Sustenna$767$93,54664 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$345$84,651134 claims
Astellas Pharma US IncMyrbetriq$541$30,41826 claims
MerckJanuvia$184$20,90017 claims
BayerKerendia$555$16,01821 claims
UCB, Inc.Neupro$21$9,32611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Shelby

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →